Menopause status at diagnosis is known to affect breast cancer prognosis, with premenopausal women often presenting with more aggressive subtypes, while postmenopausal women more commonly have hormone receptor-positive subtypes [1]. The gene discussed is NR4A1; the disease is breast cancer.